Nenad Naumovski

Prof. Nenad Naumovski

University of Canberra
+2
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Food Research International
Verified
Journal Article
Closed access
Anka Trajkovska PetkoskaAnka Trajkovska Petkoska
Anka Trajkovska Petkoska
DDDavor Daniloski
Davor Daniloski
NDNathan D'Cunha
Nathan D'Cunha
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Anita Trajkovska-BroachAnita Trajkovska-Broach
Anita Trajkovska-Broach

3 May 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
DSDomenico Sergi
Domenico Sergi
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
LHLeonie Heilbronn
Leonie Heilbronn
MAMahinda Abeywardena
Mahinda Abeywardena
NONathan O’callaghan
Nathan O’callaghan
NLNatalie Luscombe-Marsh
Natalie Luscombe-Marsh
Mitochondrial dysfunction has been implicated in the pathogenesis of insulin resistance, the hallmark of type 2 diabetes mellitus (T2DM). However, the cause-effect relationship remains to be fully elucidated. Compelling evidence suggest that boosting mitochondrial function may represent a valuable therapeutic tool to improve insulin sensitivity. Mitochondria are highly dynamic organelles which adapt to short- and long-term metabolic perturbations by undergoing fusion and fission cycles, spatial rearrangement of the electron transport chain complexes into supercomplexes as well as biogenesis governed by peroxisome proliferator-activated receptor γ co-activator 1 α (PGC 1α). However, these processes appear to be dysregulated in type 2 diabetic individuals. Herein we describe the mechanistic link between mitochondrial dysfunction and insulin resistance in skeletal muscle alongside the intracellular pathways orchestrating mitochondrial bioenergetics. We then review current evidence on nutritional tools, including fatty acids, amino acids, caloric restriction and food bioactive derivatives which may enhance insulin sensitivity by therapeutically targeting mitochondrial function and biogenesis

20 May 2019 in Gerontology
Verified
Journal Article
Open access
PDF file
NDNathan D'Cunha
Nathan D'Cunha
DNDung Nguyen
Dung Nguyen
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Andrew McKuneAndrew McKune
Andrew McKune
JKJane Kellett
Jane Kellett
SIStephen Isbel
Stephen Isbel
Assistive technology including virtual reality and augmented reality has gained interest as a novel intervention in a range of clinical settings. This technology has the potential to provide mental stimulation, a connection to autobiographical memory through reminiscence, and enhanced quality of life (QoL) to people living with dementia (PLWD) and mild cognitive impairment (MCI). In this mini-review, we examine the available evidence from studies reporting on the potential benefits of virtual and augmented reality to provide enjoyable, leisurely activities that may promote QoL and psychological well-being and facilitate social interaction. In total, 10 studies of varying study designs and durations (5 min to 6 months) using virtual (n = 9) and augmented reality (n = 1) were examined in PLWD (n = 6) and MCI (n= 3), in addition to 1 study that included participants with both conditions. Overall, the virtual experiences were enjoyed by the participants, improved their mood and apathy, and were preferred when compared with nonvirtual experiences. However, small sample sizes and variations in study design limit the generalizability of the results. Nevertheless, the use of virtual and augmented reality technology for PLWD and MCI is a novel and emerging method which may provide cognitive stimulation and improve well-being. Future research should explore the potential application of this technology to promote social interaction in both the community and aged care settings. We suggest future studies in PLWD and MCI assess the effects of more sustained use of virtual and augmented reality technology on psychological outcomes including QoL, apathy, and depressive symptoms, with the incorporation of physiological biomarker outcomes.

28 April 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
HSHollie Speer
Hollie Speer
NDNathan D'Cunha
Nathan D'Cunha
NANatalie I. Alexopoulos
Natalie I. Alexopoulos
Andrew McKuneAndrew McKune
Andrew McKune
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
Consumption of anthocyanins (ACNs), due to their antioxidant, anti-inflammatory and anti-apoptotic effects, has been proposed for the prevention and treatment of several different diseases and conditions. ACNs are recognized as one of the leading nutraceuticals for prolonging health benefits through the attenuation of oxidative stress, and inflammatory or age-related diseases. Increased consumption of ACNs has the potential to attenuate the damage ensuing from oxidative stress, inflammation, enhance cardiometabolic health, and delay symptoms in predisposed neuropathology. A myriad of evidence supports ACN consumption as complementary or standalone treatment strategies for non-communicable diseases (NCDs) including obesity, diabetes, cardiovascular disease (CVD), neurodegenerative diseases, as well as, more recently, for the modulation of gut bacteria and bone metabolism. While these findings indicate the beneficial effects of ACN consumption, their food sources differ vastly in ACN composition and thus potentially in their physiological effects. Consumption of foods high in ACNs can be recommended for their potential beneficial health effects due to their relatively easy and accessible addition to the everyday diet.

18 December 2017 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
CFCasuarina Forsyth
Casuarina Forsyth
MKMatina Kouvari
Matina Kouvari
NDNathan D'Cunha
Nathan D'Cunha
EGEkavi Georgousopoulou
Ekavi Georgousopoulou
DPDemosthenes Panagiotakos
Demosthenes Panagiotakos
Nenad NaumovskiNenad Naumovski
Nenad Naumovski

1 August 2018 in Current Opinion in Food Science
Verified
Journal Article
Closed access
Senaka RanadheeraSenaka Ranadheera
Senaka Ranadheera
Nenad NaumovskiNenad Naumovski
Nenad Naumovski
SASaid Ajlouni
Said Ajlouni